Clinical Trial Update: Syndecan-4 as a Biomarker in Patients With Chagas Disease

View source ↗

Summary

A completed clinical trial evaluating Syndecan-4 as a biomarker in patients with Chagas disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chagas Disease

Snippet

Sponsor: Hospital Sao Rafael | Conditions: Chagas Disease | Status: COMPLETED